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Abstract 
It has been suggested that bibliometric analysis of different document types may reveal new aspects of research 
performance. In medical research a number of study types play different roles in the research process and it has 
been shown, that the evidence-level of study types is associated with varying citation rates. This study focuses on 
clinical practice guidelines, which are supposed to gather the highest evidence on a given topic to give the best 
possible recommendation for practitioners.  
The quality of clinical practice guidelines, measured using the AGREE score, is compared to the citations given 
to the references used in these guidelines, as it is hypothesised, that better guidelines are based on higher cited 
references.  
AGREE scores are gathered from reviews of clinical practice guidelines on a number of diseases and treatments. 
Their references are collected from Web of Science and citation counts are normalised using the item-oriented z-
score and the PPtop-10% indicators. 
A positive correlation between both citation indicators and the AGREE score of clinical practice guidelines is 
found. Some potential confounding factors are identified. While confounding cannot be excluded, results 
indicate low likelihood for the identified confounders. The results provide a new perspective to and application 
of citation analysis. 
Conference Topic 
Old and New Data Sources for Scientometric Studies: Coverage, Accuracy and Reliability (Topic 2) and Science 
Policy and Research Evaluation: Quantitative and Qualitative Approaches (Topic 3) 
Introduction 
While most scientometric studies of research publications focus on standard journal articles, it 
has been suggested several times that other document types may play a role in research 
assessment as well (Lewison, 2002, 2003; van Leeuwen, Costas, Calero-Medina, & Visser, 
2012). Lewison (2002, 2003) in particular has emphasised the possibilities of various 
document types in the medical fields. One document type particular to that field is the clinical 
practice guideline. The purpose of these guidelines is to gather the best evidence of the 
treatment of diseases to ensure the best possible treatment at hospitals, clinics and general 
practices (The AGREE Collaboration, 2003). One might therefore expect these guidelines to 
build on the highest quality research available. 
 
Studies have shown a connection between citation scores and the evidence-level of clinical 
study types (e.g. Andersen & Schneider, 2011; Kjaergard & Gluud, 2002; Patsopoulos, 
Analatos, & Ioannidis, 2005). These study types are hierarchically ordered, assigning greater 
importance to the evidence found in high-level studies, such as meta-analyses and 
randomised, controlled trials (RCT), than lower level studies, such as case studies 
(Greenhalgh, 2010). This hierarchy is widely applied in different areas of health research, and 
the connection between citations and evidence levels indicates that high-evidence studies are 
indeed, on average, used more than other. We might thus speculate if not references used in 
clinical practice guidelines are cited more on average than other papers, if the guidelines 
indeed represent the best available evidence on a topic. 
Several studies have indicated that clinical practice guidelines are created very differently, 
with great variation in scope, rigor, clinical recommendation and overall quality (e.g. Burda, 
Norris, Holmer, Ogden, & Smith, 2011; Ferket et al., 2010, 2011; Freel et al., 2008; Gallardo 
et al., 2010; Kis et al., 2010). Many of these reviews of clinical practice guidelines use the 
AGREE
1
 instrument (The AGREE Collaboration, 2003) to assess six major aspects of 
guideline development. Especially one aspect, rigor of development, is directly related to the 
evidence found in the background literature. 
 
The hypothesis presented here is that there is a 
positive correlation between the rigor of 
development AGREE score of clinical practice 
guidelines and the citations given to the 
literature references in these clinical practice 
guidelines. If this correlation can be observed it 
points at an association between clinical 
evidence, citations and the development of 
clinical practice guidelines. The association 
cannot be assumed to be causative, however, 
but would still provide valuable insights into 
the inclusion and interpretation of a new 
document type in research assessment. 
Paper outline 
The following section outlines the acquisition 
of data, from reviews of clinical guidelines 
(top-level) to the actual guidelines and their 
references. This is followed by a presentation 
of the citation indicators used to assess the 
citation impact of the references of the 
guidelines. These references will also be 
discussed further in the results section which 
begins with an analysis of the citations given to 
the references, to test if they are representative 
of a standard citation distribution. The section 
concludes with a correlation analysis of the 
tested indicators versus the AGREE scores. All 
results are discussed in the final section and 
known weaknesses of this study are presented 
and discussed with respect to the findings. 
Materials and Methods 
The AGREE instrument consists of 23 key items organised in six domains, with the intention 
of describing various aspects of guideline development. The six domains are scope and 
purpose; stakeholder involvement; rigor of development; clarity and presentation; 
applicability; and editorial independence (The AGREE Collaboration, 2003). These domain 
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Figure 1 - Flowchart of inclusion and 
exclusion criteria 
scores have been used in a number of reviews of guideline quality as a means of assessment. 
Each item in the six domains is rated by one or more reviewers on a 4-point scale where 1 = 
strongly disagree, 2 = disagree, 3 = agree and 4 = strongly agree. In some of the included 
studies (see below) the overall domain scores were not calculated before all reviewers agreed 
on one, final item score while others used combined, standardised scores [1], resulting in a 
more diverse score profile, but also some inter-reviewer inconsistency. In this study the 
domain scores are included regardless of which procedure had been used, although it could 
have been preferable if all scores had been standardised. The reasoning behind this decision is 
elaborated in the discussion. 
 
                                     
                                             
       [1] 
 
Data collection 
To obtain the AGREE scores, reviews of clinical practice guidelines were found in PubMed 
Medline using the query:  
 
“practice guidelines as topic*”[MESH] AND “agree”[TIAB] AND “review”[PTYP] AND 
“2007”:”2011”[PDAT] AND “English”[LANG] 
 
This resulted in 79 English-language reviews of clinical practice guidelines from 2007 to 
2011 with the term agree occurring in the title or abstract. Not all reviews included the 
detailed AGREE scores, e.g. only reporting a cumulative score although this is not 
recommended (The AGREE Collaboration, 2003). Also reviews of non-disease topics were 
excluded, as were those reviews containing pure AGREE scores rather than percentages. An 
overview of the selection process is presented in figure 1. The final set of reviews (Nr = 14) 
were used to collect references to clinical practice guidelines (Np = 231), and to gather 
AGREE scores for these.  
 As stated in the present hypotheses, it is assumed that there is a connection between the scores 
of the rigor of development domain (henceforth referred to as A3) and the citations given to 
references used by the clinical practice guidelines. It is therefore necessary to retrieve the 
reference lists of the above guidelines in a database where information about citations was 
also available. The Thomson Reuters Web of Science (WoS) was used for this purpose, and 
citations from all citation indices were included. 
Many of the guidelines are not registered in WoS (N = 147), as they are often published in 
different channels, e.g. society websites. Those that were retrieved and contained reference 
lists (Np = 80), however, resulted in a total of 5,970 non-unique references in their reference 
lists. The AGREE scores of all guidelines are shown in Figure 2, illustrating the variation 
between the six domains, stressing the importance of using A3 rather than a cumulated score 
for all six domains. The cumulated score, Acum, in Figure 2 was calculated as a weighted 
average, weighting each domain by the number of items in that domain. Figure 2 also shows 
the difference between the A3 score for the 80 included guidelines and for the 147 excluded 
guidelines. As can be seen, the difference in score is very small, and the included sample can 
be considered representative of the complete 231 guidelines in this respect. 
 
The references from the guidelines were retrieved from WoS, including total number of 
citations per January 2
nd
, 2013. To provide a comparison baseline, all papers published in the 
same journals, the same years as the included references, were also gathered from WoS, 
resulting in 672,819 items. 
Citation analysis 
The included clinical practice guidelines were published in a number of different areas of 
medicine, with varying citation potentials, and their reference lists spanned publications from 
1932 to 2010. To enable comparison between these items, citation counts were normalised, 
using two different approaches. A somewhat direct comparison method was desired, but also 
an excellence-method could provide different perspectives on the meaning of citation counts 
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Figure 2 – AGREE scores for all studies (left); A1: scope and purpose, A2: stakeholder 
involvement, A3: rigor of development, A4: clarity and presentation, A5: applicability, A6: 
editorial independence, Acum: cumulated, weighted scores. The figure to the right shows the 
difference in A3 score for guidelines included in the study and those that could not be found in 
Web of Science (excluded). 
as a function of agree scores. For the latter, the PPtop-10% indicator (Waltman et al., 2012) is 
considered a sensible choice, as it both focuses on the 10% most highly cited papers (a form 
of excellence) and remains insensitive to extremely highly cited documents. For the more 
direct approach, a number of normalisation procedures are available, but the item-oriented z-
score (Lundberg, 2007) has been chosen here, as it allows normalisation of single items while 
also incorporating standard scores. The item-oriented z-score for a single item, zi, is denoted 
as: 
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, where ci is the number of citations given to a document published in a specific journal a 
specific year, taken from c, the entire distribution of citations to papers in that journal that 
year.  ̅  is the average of the    distribution and  (  ) is the standard deviation of the    
distribution. The cumulative z for a clinical practice guideline is the average zi for all 
references in the reference list. Values of z indicate the number of standard deviations the 
citations diverge from the mean. Positive values indicate higher than average scores. 
 
The PPtop-10% indicator is simply found by comparing the citations to each paper to those of all 
other papers published in the same journal and year. If the citation score is placed in the 
highest decile, it is counted as 1, if not as 0. The PPtop-10% is the average of this distribution, 
resulting in a percentage of papers in the reference list that are considered excellent. If this 
percentage is higher than 10%, the references could be considered to be more excellent than 
standard publications. One should however be careful to draw the same conclusions in the 
setting of this study than one would for e.g. the publications of a university, as is the case in 
the Leiden ranking (Waltman et al., 2012). As all references in a reference list are de facto 
cited at least once, and there is an increased chance that highly cited documents are used as 
references, a PPtop-10% over 0.1 should not be interpreted as better than average. The 
interpretation of whether the hypothesis of this study has merit thus depends on whether an 
increase in PPtop-10% or z can be observed as a function of A3. 
Both citation indicators are calculated for individual references and subsequently cumulated 
for the guidelines. By doing so, both indicators enable comparison between guidelines, 
without bias from the length of reference lists, which varies greatly (from 4 to 627 with a 
median of 81). 
 
All data extraction and calculations were performed using R version x64 2.15.2 (R 
Development Core Team, 2010) 
Results 
The citations given to references from the guidelines are plotted as a decreasing function of 
rank in Figure 3. The shape of the curve is as could be expected for a typical citation 
distribution, indicating that the sample of references is comparable to other citation 
distributions. The distribution of z-scores reveals that the citations are higher than the 
background population though, as the median z-score is 0.9, and thus almost one standard 
deviation higher than the expected average. This is also illustrated in Figure 4, showing the 
empirical cumulative density function for the z-score of all references. 
 Figure 3 – citation counts as a function of rank, double-log scales 
 
Figure 4 – empirical cumulative density function of z-scores for references 
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As is stated in the above, one might expect citation distributions for documents retrieved from 
reference lists to be higher than complete citation distributions of journals, as they represent 
documents that are actually used as references while a certain proportion of all journal articles 
remain uncited even after several years. 
To test the correlation between A3, z and PPtop-10% respectively the two citation indicators 
were plotted as functions of A3 in Figure 5.  
 
 
Figure 5 – Cumulative z-scores of clinical practice guidelines as a function of A3 (left), and PPtop-
10% of clinical practice guidelines as a function of A3 (right). Solid lines are fitted linear 
regression lines. 
 
As can be seen from Figure 5, there is a seemingly positive correlation for both citation 
indicators. Linear regression was performed on the data and regression lines were fitted to the 
plots (solid lines). The residuals from the regressions showed no systematic error, and Q-Q 
plots of the residuals showed approximately normally distributed residuals (Figure 6), with 
only few outliers. Thus there is no reason to assume more complex correlations, despite the 
large variation of data. 
 
 
Figure 6 - Diagnostic plots for linear regressions. Residuals and Q-Q for z to the left and to the 
right for PPtop-10%. 
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 The increase in the two indicators as a function of A3 can be considered very high. For the z-
score, the regression line increases from .6 to 1.4 standard deviations. This accounts for a very 
large increase, and can be interpreted as moving from “mainstream” to “top science”. For the 
PPtop-10% indicator a similar pattern emerges, with an increase from approximately .27 to .59 
(59% of all references belong to the top-10% of the highest cited papers in their respective 
journals). 
 
Several other factors may be influencing the correlations, some of which are not directly 
related to bibliometric data and some are. There is a risk of confounding error from the 
number of references of the clinical practice guidelines as well as the citations given to the 
guidelines themselves. The two citation indicators are thus plotted as functions of number of 
references and citations per year respectively, displayed in Figure 7. The first column in 
Figure 7 shows the correlation between the citation indicators and number of references in the 
clinical practice guidelines, the middle column the correlation between citation indicators and 
the annual citations received by the clinical practice guidelines. The latter is potentially 
related to the mechanism described by this study, therefore the AGREE scores A3 and Acum 
are plotted in the final column, as a function of annual citations received. All plots have 
regression lines to show the general tendencies. The statistical strength of the PPtop-10% 
regressions is low (not statistically significant, p>0.05), while the other regressions are 
somewhat stronger (p<0.05), especially the A3 and Acum regressions (p<0.01). This should 
also be apparent from a visual interpretation of the six plots in Figure 7, and the meaning of 
these will be discussed further in the following section. 
 
Figure 7 - Citation indicators as functions of number of references in clinical practice guidelines 
(left), citations per year given to clinical practice guidelines (middle) and correlation between A3 
(top-right), Acum (bottom-right) and citations per year. 
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Discussion 
The purpose of this study is to investigate the potential association between AGREE 
assessments of clinical practice guidelines and the citation scores of references used by these 
guidelines. The hypothesis states a positive correlation, as guidelines scoring highly on the 
AGREE domain rigor of development are assumed to build on better evidence which is here 
speculated to be associated with higher citation scores based on increased citations to study 
types associated with higher citation rates (Andersen & Schneider, 2011; Kjaergard & Gluud, 
2002; Patsopoulos et al., 2005). Positive correlations are found, and the increased effect from 
the lowest A3 scores to the highest is considered very large. While this informs us about a 
strong association between citations to references and guideline development quality we 
cannot assume any mechanisms behind the association, as several models might explain the 
behaviour. From a bibliometric viewpoint, a plausible and interesting cause for the positive 
relationship is related to the interpretation of citations and the indicated relationship with 
clinical evidence. This study adds an argument to the hypothesis that clinical studies receive 
more citations if they provide more (relevant) evidence. An important caveat is the distinction 
between clinical research and other medical research, e.g. biomedical, as clinical research 
mostly is concerned with the testing and application of treatments. Therefore clinical practice 
guidelines will generally rely on clinical research, as it is usually closer to practice as more 
basic research areas. If biomedical studies are not included in clinical practice guidelines it is 
thus not a question of missing evidence, but rather of different evidence types, and 
conclusions about citability or citation scores should thus not be transferred from clinical 
research to biomedical. 
A different, plausible mechanism, which is likely also affecting the results presented here, is 
the increased focus on the references used in clinical practice guidelines. It is not unlikely that 
articles will receive more attention, once they have been cited by a clinical practice guideline, 
ultimately leading to an increase in citations. This mechanism could be investigated further, 
but would require more elaborate data on citations per year than was acquired for this study. 
 
As stated above, there is a danger of confounding errors from other sources when doing these 
types of analysis. Two potential confounding factors were mentioned previously, namely 
number of references in the guidelines and the citations given to the guidelines. The number 
of references might influence the results either way, as e.g. a short reference list might 
indicate a focus on only the very best evidence, but also a failure to include important 
evidence. The plots with number of references as the independent variable illustrate much 
larger variation for short reference lists than for the longer ones, but also that the reference list 
length is practically unrelated to the citation indicators, with almost horizontal regression lines 
roughly around the sample mean of the citation indicators. There is however a positive 
correlation between the annual citation counts of the clinical practice guidelines and the 
citation impact of their references. This effect can be explained by both of the causative 
models presented above. If the mention of citations in guidelines leads to higher citation 
scores for their references, it could be expected that the use of an article as a reference in a 
highly cited guideline would lead to a greater attention increase than the use in a less cited 
guideline. The evidence-mechanism, on the other hand, implies that the studies with the 
highest AGREE-scores would refer to the best evidence and by proxy contain good evidence 
themselves. Therefore one would also expect the citation scores of the guidelines with the 
highest AGREE-scores to be higher than those with low AGREE-scores. This is indeed the 
case, as can be seen in the rightmost plots in Figure 7, showing a clearly increasing function 
for both A3 and Acum when plotted as a function of citations per year to the clinical practice 
guidelines. This provides further evidence that the proposed mechanism has merit, but both 
causative models may yet be active at the same time. 
 The A3 score used in the present study is far from being a perfect measurement of the degree 
of foundation on evidence. The measurement is subjective and designed for an entirely 
different purpose as applied here, which however has the advantage of making the above 
usage unobtrusive, thereby removing one type of potential bias. More critical weaknesses of 
the measure, in the current context, are the differences in application and the meaning of the 
individual items of the A3 domain score. As was mentioned in the methods section, some 
guideline reviews implemented an interpretation of the AGREE instrument where all 
assessors needed to agree on each item score, where other reviews used a standardised 
approach allowing for inter-assessor inconsistency. One might argue for the benefits of each 
approach, and the arguments from a clinical standpoint are likely to be different than from a 
bibliometric one. While a uniform approach would have been preferable, the difference was 
not considered a major problem in this context, however, as the focus is on the overall 
increase in effect from the lowest scores to the highest. Given the broadly distributed scores in 
each AGREE domain, the potential error from the different approaches is considered 
negligible, and both approaches are included. 
Not all of the seven items in the A3 domain are directly related to the background literature, 
although most are. It is not possible to deduce how well each guideline scored in each item 
from the final score, and only very few reviews reported the full background data. Two 
guidelines with equal scores might thus represent different scores for the items most closely 
related to the mechanism described in this study. For the extreme cases, i.e. the lowest and 
highest scores, the problem is not as large as for the mid-range, where the potential for error is 
much larger. The problem is thus not as relevant when regarding the overall effect, and some 
of the variance could be explained by this issue. 
 
The final weakness of the study to be discussed here is the use of journal-specific 
normalisation methods for citation indicators. While the normalisation as such is regarded as a 
strength, as it allows comparison between papers with different citation potentials, it is 
debatable whether other normalisation methods might be more appropriate. A common 
normalisation procedure is the field-normalisation, in which citations are normalised with 
respect to the entire field rather than merely the journal. It has been argued by e.g. 
Leydesdorff & Bornmann (2011) that field definitions are not clearly representative of the 
citation potentials of the individual journals in some field category definitions. It is thus not 
given that a field-normalisation would necessarily improve the design of this study. 
 
The results presented here indicate an association between clinical evidence, citation rates and 
the quality of clinical guidelines dependant on the degree to which they are based on 
evidence. This association may be useful for research assessment, studies on clinical impact 
and provides insight into one of the many mechanisms behind citations. The use of a study as 
a reference in a well-developed clinical practice guideline may be seen as a mega-citation in 
some respects, as it very clearly indicates usefulness in a practice-setting, which is otherwise 
difficult to capture with traditional citation measures. It has been stressed that impact in a 
broad perspective has many other aspects than research (citation) impact (Kuruvilla, Mays, 
Pleasant, & Walt, 2006). While many of the impact types described by Kuruvilla et al. are not 
related to citation analysis at all, the observations in this study allow us to broaden the 
application of citation analysis to e.g. health policy and practice impact studies, while in no 
way claiming to cover all facets of these complex subjects. 
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